(Total Views: 684)
Posted On: 01/05/2020 10:30:58 AM
Post# of 148984
2020, what a YEAR. January, what a MONTH for us who patiently watched the share price drop, and ignored noises of inexperienced across boards in the last year.
I'm calm NOW, and know clearly the BK is off the table, and having the SERIAL indication drug.
2020, what a YEAR...Below, is what I'm expecting to see...
January, what a MONTH
- BLA Combo
- BTD Cancer (or FDA discussion to file in Feb)
- Indication by NP again, with more specific number (more specific than $1B and $100m upfront) on NASH licencing.
- More Cancer patients registered.
- Some update on Skerli's corp
- Share price flirting with $2
Feb
- Clean up on the above checklist.
- Update on Mono strategy (plan and timelines)
- NASH non-binding announcement.
- More indication
- Updates on manufacturing.
- Share price flirting with $2.5
March
- NASH licensing deal.
- More indication
- More names and interests.
April-July:
- BLA Acceptance
- FDA protocol for Cancer
- NASH initiation
- Share price roaming between $5 to $10
August:
- Me stopping from working for other people in my current role.
Nov- Dec:
Vegas party (as Mexico might be too dangerous for big group of rich people all together)
What a dream, that now, with higher odds can become reality !
I'm sure, I missed many major milestones.
2020, is the year to chill and get rewarded for our patience.
I'm calm NOW, and know clearly the BK is off the table, and having the SERIAL indication drug.
2020, what a YEAR...Below, is what I'm expecting to see...
January, what a MONTH
- BLA Combo
- BTD Cancer (or FDA discussion to file in Feb)
- Indication by NP again, with more specific number (more specific than $1B and $100m upfront) on NASH licencing.
- More Cancer patients registered.
- Some update on Skerli's corp
- Share price flirting with $2
Feb
- Clean up on the above checklist.
- Update on Mono strategy (plan and timelines)
- NASH non-binding announcement.
- More indication
- Updates on manufacturing.
- Share price flirting with $2.5
March
- NASH licensing deal.
- More indication
- More names and interests.
April-July:
- BLA Acceptance
- FDA protocol for Cancer
- NASH initiation
- Share price roaming between $5 to $10
August:
- Me stopping from working for other people in my current role.
Nov- Dec:
Vegas party (as Mexico might be too dangerous for big group of rich people all together)
What a dream, that now, with higher odds can become reality !
I'm sure, I missed many major milestones.
2020, is the year to chill and get rewarded for our patience.
(6)
(0)Scroll down for more posts ▼
